<code id='571B3E1BDF'></code><style id='571B3E1BDF'></style>
    • <acronym id='571B3E1BDF'></acronym>
      <center id='571B3E1BDF'><center id='571B3E1BDF'><tfoot id='571B3E1BDF'></tfoot></center><abbr id='571B3E1BDF'><dir id='571B3E1BDF'><tfoot id='571B3E1BDF'></tfoot><noframes id='571B3E1BDF'>

    • <optgroup id='571B3E1BDF'><strike id='571B3E1BDF'><sup id='571B3E1BDF'></sup></strike><code id='571B3E1BDF'></code></optgroup>
        1. <b id='571B3E1BDF'><label id='571B3E1BDF'><select id='571B3E1BDF'><dt id='571B3E1BDF'><span id='571B3E1BDF'></span></dt></select></label></b><u id='571B3E1BDF'></u>
          <i id='571B3E1BDF'><strike id='571B3E1BDF'><tt id='571B3E1BDF'><pre id='571B3E1BDF'></pre></tt></strike></i>

          explore

          explore

          author:hotspot    Page View:54
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

          advertisement

          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Chan Zuckerberg Biohub Chicago to focus on inflammation
          Chan Zuckerberg Biohub Chicago to focus on inflammation

          PriscillaChan,left,withShanaKelleyandGov.J.B.PritzkerofIllinoisatthenewCZBiohubChicago.CourtesyDaleR

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          Vertex cell therapy lets patients with type 1 diabetes stop insulin

          CraigF.Walker/TheBostonGlobeVertexPharmaceuticalssaidFridaythat,overayearafterreceivingthecompany’ss